R2 Technology is making machines smarter and, in the process, easing the transition to digital mammography.
R2 Technology is making machines smarter and, in the process, easing the transition to digital mammography.
The CAD developer's Citra Mammography Applications Suite, launched at the 2005 RSNA meeting, includes software tools that automatically scale mammograms to the display window, sizing the previous mammogram with the current image, regardless of the system used to capture the images or the amount of compression placed on the breasts.
In a separate development, the company enhanced its ImageChecker mammography CAD technology. One new feature, built into Version 8.1, identifies regions of breast tissue that contain both a mass and calcifications. Another assigns variable-sized CAD marks to indicate the potential for malignancy.
This latest version also allows users to set the sensitivity of the machine to flag more or fewer anomalies. Separate controls are available for microcalcifications and for masses.
The introductions reflect a corporate strategy to promote the use of CAD as a way to make radiologists' lives easier. This strategy, and how it will affect R2 products in the future, will be featured in the next issue of DI SCAN, available online Dec. 19.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.